Rapport Therapeutics (RAPP) Institutional Ownership $11.19 +0.05 (+0.45%) Closing price 04:00 PM EasternExtended Trading$12.08 +0.90 (+8.00%) As of 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Rapport Therapeutics (NASDAQ:RAPP)Number ofInstitutional Buyers(last 12 months)49TotalInstitutional Inflows(last 12 months)$172.38MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$3.93M Get RAPP Insider Trade Alerts Want to know when executives and insiders are buying or selling Rapport Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RAPP Institutional Buying and Selling by Quarter Rapport Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2025 Rhumbline Advisers14,358$144K0.0%+40.1%0.039% 5/23/2025 Siren L.L.C.378,469$3.80M0.2%-1.5%1.037% 5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC203,242$2.04M0.0%N/A0.557% 5/16/2025 Goldman Sachs Group Inc.1,244,310$12.48M0.0%-0.6%3.409% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.9,887$99K0.0%+86.4%0.027% 5/15/2025 Siren L.L.C.378,469$3.80M0.2%-1.5%1.037% 5/14/2025 Corebridge Financial Inc.8,271$83K0.0%+79.1%0.023% 5/14/2025 MetLife Investment Management LLC10,863$109K0.0%+90.2%0.030% 5/14/2025 Jump Financial LLC13,760$138K0.0%N/A0.038% 5/14/2025 T. Rowe Price Investment Management Inc.1,551,925$15.57M0.0%-5.2%4.252% Get the Latest News and Ratings for RAPP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/12/2025 Nuveen LLC21,873$219K0.0%N/A0.060% 5/12/2025 Swiss National Bank31,900$320K0.0%+77.2%0.087% 5/9/2025 Deutsche Bank AG6,502$65K0.0%+180.6%0.018% 5/9/2025 Charles Schwab Investment Management Inc.90,968$912K0.0%+23.8%0.249% 5/8/2025 XTX Topco Ltd15,442$155K0.0%N/A0.042% 5/7/2025 TD Asset Management Inc162,818$1.63M0.0%-8.5%0.446% 4/30/2025 Alps Advisors Inc.26,128$262K0.0%-11.7%0.072% 4/29/2025 Bank of New York Mellon Corp35,482$356K0.0%+77.7%0.097% 4/8/2025 Rhumbline Advisers14,358$144K0.0%+40.1%0.039% 4/8/2025 Catalyst Private Wealth LLC10,000$100K0.0%N/A0.027% 4/7/2025 GAMMA Investing LLC9,208$918K0.0%+91,980.0%0.025% 3/18/2025 California State Teachers Retirement System8,571$152K0.0%+1,151.2%0.023% 2/17/2025 Woodline Partners LP181,530$3.22M0.0%-2.7%0.496% 2/17/2025 Deutsche Bank AG2,317$41K0.0%N/A0.006% 2/17/2025 Crestline Management LP27,496$488K0.0%N/A0.075% 2/17/2025 Bank of America Corp DE6,578$117K0.0%-65.6%0.018% 2/17/2025 Acuta Capital Partners LLC16,400$291K0.3%-6.8%0.045% 2/14/2025 Virtus ETF Advisers LLC3,740$66K0.0%N/A0.010% 2/14/2025 T. Rowe Price Investment Management Inc.1,636,931$29.04M0.0%-5.2%4.475% 2/14/2025 Price T Rowe Associates Inc. MD1,143,384$20.29M0.0%+9.2%3.126% 2/14/2025 TRV GP V LLC7,135,233$126.58M43.1%N/A19.506% 2/14/2025 TRV GP VI LLC969,218$17.19M14.7%N/A2.650% 2/13/2025 Barclays PLC18,497$328K0.0%+43.8%0.051% 2/13/2025 Legal & General Group Plc9,523$169K0.0%+947.6%0.026% 2/13/2025 Wells Fargo & Company MN4,824$86K0.0%+38.9%0.013% 2/12/2025 Geode Capital Management LLC210,676$3.74M0.0%+4.4%0.576% 2/12/2025 Alliancebernstein L.P.1,098,415$19.49M0.0%+0.9%3.003% 2/12/2025 Norges Bank48,452$860K0.0%N/A0.132% 2/12/2025 JPMorgan Chase & Co.7,170$127K0.0%+77.8%0.020% 2/11/2025 KLP Kapitalforvaltning AS1,900$34K0.0%N/A0.005% Utah’s New Oil Find (Ad)The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.Find out why this could be the most lucrative "underground" energy story in America2/10/2025 Swiss National Bank18,000$319K0.0%N/A0.049% 1/31/2025 New York State Common Retirement Fund3,500$62K0.0%N/A0.010% 1/30/2025 Rhumbline Advisers10,249$182K0.0%-35.3%0.028% 1/24/2025 Jennison Associates LLC62,287$1.11M0.0%N/A0.170% 1/24/2025 China Universal Asset Management Co. Ltd.7,756$138K0.0%N/A0.021% 12/26/2024 JPMorgan Chase & Co.4,033$83K0.0%N/A0.011% 11/19/2024 Barclays PLC12,863$264K0.0%+36.8%0.035% 11/16/2024 Geode Capital Management LLC201,748$4.13M0.0%N/A0.552% 11/15/2024 Barclays PLC12,863$264K0.0%+36.8%0.035% 11/15/2024 State Street Corp58,046$1.19M0.0%N/A0.159% 11/15/2024 Maven Securities LTD29,930$613K0.0%N/A0.082% 11/14/2024 Eventide Asset Management LLC110,401$2.26M0.0%+120.8%0.302% 11/14/2024 Acuta Capital Partners LLC17,600$360K0.3%-12.0%0.048% 11/14/2024 MetLife Investment Management LLC5,710$117K0.0%N/A0.016% 11/13/2024 BNP Paribas Financial Markets1,684$34K0.0%N/A0.005% 11/13/2024 FMR LLC5,486,468$112.36M0.0%+10.1%14.999% 11/13/2024 The Manufacturers Life Insurance Company77,344$1.58M0.0%+2.4%0.211% 11/12/2024 Charles Schwab Investment Management Inc.73,146$1.50M0.0%N/A0.200% 11/7/2024 LMR Partners LLP20,000$410K0.0%-60.0%0.055% 10/23/2024 Values First Advisors Inc.1,507$31K0.0%N/A0.004% 10/3/2024 SG Americas Securities LLC4,934$101K0.0%N/A0.014% 8/27/2024 Logos Global Management LP208,910$4.86M0.4%N/A0.591% 8/16/2024 Perceptive Advisors LLC748,183$17.40M0.4%N/A2.045% 8/15/2024 The Manufacturers Life Insurance Company75,516$1.76M0.0%N/A0.206% 8/15/2024 Millennium Management LLC116,782$2.72M0.0%N/A0.319% 8/14/2024 Squarepoint Ops LLC16,345$380K0.0%N/A0.045% 8/14/2024 Sandia Investment Management LP5,000$116K0.2%N/A0.014% 8/14/2024 ARCH Venture Management LLC3,728,738$86.73M31.6%N/A10.193% 8/14/2024 Davidson Kempner Capital Management LP10,000$229K0.0%N/A0.027% 8/10/2024 Sofinnova Investments Inc.1,951,562$45.39M2.4%N/A5.516% 8/9/2024 Johnson & Johnson2,498,051$58.11M14.5%N/A7.061% 8/3/2024 TD Asset Management Inc101,522$2.36M0.0%N/A0.287% (Data available from 1/1/2016 forward) RAPP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RAPP shares? During the previous two years, 57 institutional investors and hedge funds held shares of Rapport Therapeutics. The most heavily invested institutionals were TRV GP V LLC ($126.58M), FMR LLC ($112.36M), ARCH Venture Management LLC ($86.73M), Johnson & Johnson ($58.11M), Sofinnova Investments Inc. ($45.39M), Price T Rowe Associates Inc. MD ($20.29M), and Alliancebernstein L.P. ($19.49M).Learn more on RAPP's institutional investors. Which institutional investors have been buying Rapport Therapeutics stock? Of the 49 institutional investors that purchased Rapport Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: TRV GP V LLC ($7.14M), ARCH Venture Management LLC ($3.73M), Johnson & Johnson ($2.50M), Sofinnova Investments Inc. ($1.95M), TRV GP VI LLC ($969.22K), Perceptive Advisors LLC ($748.18K), and FMR LLC ($503.12K). How much institutional buying is happening at Rapport Therapeutics? Institutional investors have bought a total of 19,180,718 shares in the last 24 months. This purchase volume represents approximately $172.38M in transactions. Which Rapport Therapeutics major shareholders have been selling company stock? Of the 10 institutional investors that sold Rapport Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: T. Rowe Price Investment Management Inc. ($175.19K), LMR Partners LLP ($30K), TD Asset Management Inc ($15.09K), Bank of America Corp DE ($12.53K), Siren L.L.C. ($11.46K), Goldman Sachs Group Inc. ($7.83K), and Rhumbline Advisers ($5.59K). How much institutional selling is happening at Rapport Therapeutics? Institutional investors have sold a total of 269,764 shares in the last 24 months. This volume of shares sold represents approximately $3.93M in transactions. Related Companies ANIP Institutional Ownership MESO Institutional Ownership OCUL Institutional Ownership GPCR Institutional Ownership AMPH Institutional Ownership CALT Institutional Ownership AUPH Institutional Ownership CVAC Institutional Ownership MLYS Institutional Ownership PAHC Institutional Ownership This page (NASDAQ:RAPP) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapport Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapport Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
